Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues
Autolus Therapeutics PLC Sponsored ADR (AUTL) had Gross Margin of -16.83% for the most recently reported fiscal quarter, ending 2025-06-30.
Income Statement Financials | |
$20.92M |
|
$-47.92M |
|
$24.45M |
|
$-3.52M |
|
$82.14M |
|
$-61.22M |
|
$13.70M |
|
$-47.52M |
|
$-47.52M |
|
$-47.92M |
|
$-47.92M |
|
$-47.92M |
|
$-47.92M |
|
$-61.22M |
|
$-58.85M |
|
266.14M |
|
266.14M |
|
$-0.18 |
|
$-0.18 |
|
Balance Sheet Financials | |
$574.25M |
|
$66.47M |
|
$146.73M |
|
$720.98M |
|
$68.15M |
|
-- |
|
$306.37M |
|
$374.52M |
|
$346.46M |
|
$333.53M |
|
$346.46M |
|
266.14M |
|
Cash Flow Statement Financials | |
$-148.35M |
|
$36.37M |
|
$-0.77M |
|
$228.81M |
|
$125.33M |
|
$-103.47M |
|
$7.16M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
8.43 |
|
-- |
|
-- |
|
-- |
|
-- |
|
Gross Margin |
-16.83% |
-292.58% |
|
-292.58% |
|
-- |
|
-227.12% |
|
-229.02% |
|
$-163.87M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
1.02 |
|
0.79 |
|
114.61 |
|
-13.83% |
|
-14.37% |
|
-6.65% |
|
-13.83% |
|
$1.30 |
|
$-0.62 |
|
$-0.56 |